Pulmonx Corp Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: LUNG · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, regulatory-filing
Related Tickers: PLNX
TL;DR
Pulmonx (PLNX) filed its proxy statement for the May 22 meeting. Shareholders vote on company proposals.
AI Summary
Pulmonx Corporation filed its definitive proxy statement (DEF 14A) on April 8, 2025, for its annual meeting scheduled for May 22, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. Pulmonx Corporation, a medical device company specializing in surgical and medical instruments, is headquartered in Redwood City, California.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions on company matters.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders about an upcoming meeting, rather than announcing significant new financial or strategic developments.
Key Numbers
- 20250522 — Annual Meeting Date (Date of the shareholder meeting where proposals will be voted on.)
- 20250408 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Pulmonx Corporation (company) — Registrant
- 0001140361-25-012814 (filing_id) — Accession Number
- 20250408 (date) — Filing Date
- 20250522 (date) — Meeting Date
- Redwood City, CA (location) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing is a definitive proxy statement filed by a company with the SEC, providing shareholders with information about matters to be voted on at an upcoming shareholder meeting.
When is the Pulmonx Corporation's annual meeting scheduled?
The Pulmonx Corporation's annual meeting is scheduled for May 22, 2025.
What is Pulmonx Corporation's primary business sector?
Pulmonx Corporation operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, SIC code 3841.
Where is Pulmonx Corporation headquartered?
Pulmonx Corporation is headquartered at 700 Chesapeake Drive, Redwood City, CA 94063.
What is the SEC file number for Pulmonx Corporation?
The SEC file number for Pulmonx Corporation is 001-39562.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 regarding Pulmonx Corp (LUNG).